Evidence map›Paper›PMID 39273463›Full record

ArticleInternational journal of molecular sciences2024

Development and Optimization of a Bromothymol Blue-Based PLA2 Assay Involving POPC-Based Self-Assemblies.

Shibbir Ahmed Khan, Marc A Ilies

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Shibbir Ahmed KhanDepartment of Pharmaceutical Sciences, Moulder Center for Drug Discovery Research, Temple University, School of Pharmacy, 3307 N Broad Street, Philadelphia, PA 19130, USA.
Marc A IliesDepartment of Pharmaceutical Sciences, Moulder Center for Drug Discovery Research, Temple University, School of Pharmacy, 3307 N Broad Street, Philadelphia, PA 19130, USA.ORCID 0000-0003-0694-411X

Funding

Interfacially-stabilized polymeric nanosystems for drug deliveryR03EB026189 · NIBIB · TEMPLE UNIV OF THE COMMONWEALTH · PI ILIES, MARC A · 2018 to 2019
$159k
NIBIB NIH HHS R03 EB026189NIH HHS R03EB026189
6 · The paper itself

Abstract

Phospholipase A2 (PLA2) is a superfamily of phospholipase enzymes that dock at the water/oil interface of phospholipid assemblies, hydrolyzing the ester bond at the sn-2 position. The enzymatic activity of these enzymes differs based on the nature of the substrate, its supramolecular assemblies (micelle, liposomes), and their composition, reflecting the interfacial nature of the PLA2s and requiring assays able to directly quantify this interaction of the enzyme(s) with these supramolecular assemblies. We developed and optimized a simple, universal assay method employing the pH-sensitive indicator dye bromothymol blue (BTB), in which different POPC (3-palmitoyl-2-oleoyl-sn-glycero-1-phosphocholine) self-assemblies (liposomes or mixed micelles with Triton X-100 at different molar ratios) were used to assess the enzymatic activity. We used this assay to perform a comparative analysis of PLA2 kinetics on these supramolecular assemblies and to determine the kinetic parameters of PLA2 isozymes IB and IIA for each supramolecular POPC assembly. This assay is suitable for assessing the inhibition of PLA2s with great accuracy using UV-VIS spectrophotometry, being thus amenable for screening of PLA2 enzymes and their substrates and inhibitors in conditions very similar to physiologic ones.

Indexed as

PhosphatidylcholinesPhospholipases A2Enzyme AssaysHydrogen-Ion ConcentrationKineticsLiposomesMicellesOctoxynol1-palmitoyl-2-oleoylphosphatidylcholineLiposomesMicellesOctoxynolPhosphatidylcholinesPhospholipases A2bromothymol blueenzymatic assayinhibition studyliposomesmixed micellesphospholipase A2pH variationPLA2 kinetic studyPOPCTriton X-100

Identifiers

PMID39273463
PMCPMC11395447

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.